DMII (Drugs Made In America Acquisition II) 12-1 Month Momentum %: N/A% (As of Jul. 11, 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II 12-1 Month Momentum %?

Drugs Made In America Acquisition II DMII 15 12-1 Month Momentum % is N/A% as of Jul. 11, 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 417 Diversified Financial Services companies, Drugs Made In America Acquisition II ranks worse than 239807.91% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-07-11), Drugs Made In America Acquisition II's 12-1 Month Momentum % is N/A%.

The industry rank for Drugs Made In America Acquisition II's 12-1 Month Momentum % or its related term are showing as below:

DMII's 12-1 Month Momentum % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 2.53
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Drugs Made In America Acquisition II  (NAS:DMII) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Drugs Made In America Acquisition II 12-1 Month Momentum % Related Terms

DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
12-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II  (NAS:DMII) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of N/A% mean?
Drugs Made In America Acquisition II (DMII) has a 12-1 Month Momentum % of N/A% as of Jul. 11, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Drugs Made In America Acquisition II and its competitors. According to the industry distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 417 companies in the Diversified Financial Services industry.
Is Drugs Made In America Acquisition II's 12-1 Month Momentum % too high?
Drugs Made In America Acquisition II's current 12-1 Month Momentum % is N/A%. Based on the distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 417 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's 12-1 Month Momentum % compare to BCSS and EVAC?
According to the Diversified Financial Services industry distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 417 companies for 12-1 Month Momentum %. This places Drugs Made In America Acquisition II in the lower half of its industry. The industry median 12-1 Month Momentum % is 2.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Diversified Financial Services company?
The median 12-1 Month Momentum % among Diversified Financial Services companies is 2.53, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Drugs Made In America Acquisition II and its competitors. For the Diversified Financial Services industry, the median 12-1 Month Momentum % is 2.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Drugs Made In America Acquisition II's current 12-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current 12-1 Month Momentum % of N/A%. The current 12-1 Month Momentum % is N/A%. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current 12-1 Month Momentum % is N/A% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price